Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors

乳腺癌和前列腺癌幸存者寻求后续护理的预测因素

基本信息

项目摘要

DESCRIPTION (provided by applicant): Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors By 2050 the estimated number of cancer survivors will surpass new cancer cases, putting great demands on service providers and systems of care. More than half of individuals already diagnosed with cancer are expected to survive for more than 5 years. For breast and prostate cancers survival exceeds 88%. The American Society of Clinical Oncology projects a medical oncologist shortage by 2020 that will necessitate a multifaceted strategy to meet future cancer follow-up care demands. Therefore, primary care providers (PCPs) are increasingly being called upon to provide a "medical home" (i.e., usual source of care) for cancer survivors who have completed treatment. Currently one third of the 36.6 million physician office visits made for cancer care annually are made to PCPs. A study of SEER linked Medicare data reports that greater proportions of long-term breast and prostate cancer survivors (75% of those surviving 5+ yrs) receive care from primary care providers than cancer and cancer related specialists. Several studies suggest that survivors who see both oncologists and primary care physicians are more likely to receive recommended follow-up care than patients who see one or the other. Yet, there is little research that examines how patients think about their options for care, their decision making processes or the impact of these factors on receiving quality follow-up care. There is also limited research on cancer survivors who receive their treatment in community settings. While most adult cancer survivors in the US are treated for their cancers in community settings, much of the current survivorship research comes from patients treated at NCI designated comprehensive cancer centers. We address these important knowledge gaps in the proposed study. Specific aims of the study are to: (1) implement a survey study of adult cancer survivors treated in community settings that assesses and measures their primary care use and attitudes regarding their follow-up cancer care; (2) describe primary care usage of breast and prostate cancer survivors for follow-up care and recurrence surveillance; and, (3) assess cognitive- affective, patient support and demographic factors that affect how survivors use oncology specialists and PCPs for follow-up care. This descriptive, cross-sectional study of breast and prostate cancer survivors (n=400) will be conducted with patients treated at six community hospitals reflective of the diversity of community cancer treatment experiences in the state of NJ. Study results will provide a sound empirical basis for the development of interventions that enhance survivor care plans and optimize follow-up care in cancer survivor populations.
描述(由申请人提供):乳腺癌和前列腺癌幸存者寻求后续护理的预测因素到2050年,癌症幸存者的估计数量将超过新发癌症病例,这对服务提供者和护理系统提出了巨大的要求。超过一半已经被诊断出患有癌症的人预计能存活5年以上。乳腺癌和前列腺癌的存活率超过88%。美国临床肿瘤学会预计,到2020年,医学肿瘤学家将出现短缺,这将需要一个多方面的战略来满足未来癌症后续护理的需求。因此,越来越多的人要求初级保健提供者(pcp)为完成治疗的癌症幸存者提供“医疗之家”(即通常的护理来源)。目前,每年因癌症治疗而就诊的3660万名医生中,有三分之一是到pcp就诊的。一项与SEER相关的医疗保险数据研究报告称,长期乳腺癌和前列腺癌幸存者(占存活5年以上患者的75%)接受初级保健提供者护理的比例高于癌症和癌症相关专家。几项研究表明,同时看肿瘤学家和初级保健医生的幸存者比只看其中之一的患者更有可能接受推荐的后续护理。然而,很少有研究调查患者如何考虑他们的护理选择,他们的决策过程或这些因素对接受高质量后续护理的影响。对在社区环境中接受治疗的癌症幸存者的研究也很有限。虽然美国大多数成年癌症幸存者在社区环境中接受癌症治疗,但目前大部分幸存者研究来自NCI指定的综合癌症中心接受治疗的患者。我们在拟议的研究中解决了这些重要的知识差距。该研究的具体目的是:(1)对在社区环境中接受治疗的成年癌症幸存者进行调查研究,评估和测量他们对初级保健的使用情况和对后续癌症护理的态度;(2)描述乳腺癌和前列腺癌幸存者在随访护理和复发监测方面的初级保健使用情况;(3)评估影响幸存者如何使用肿瘤专家和pcp进行后续护理的认知-情感、患者支持和人口因素。这项对乳腺癌和前列腺癌幸存者(n=400)的描述性横断面研究将与在六家社区医院接受治疗的患者一起进行,反映了新泽西州社区癌症治疗经验的多样性。研究结果将为制定干预措施,加强幸存者护理计划和优化癌症幸存者人群的随访护理提供良好的经验基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHAWNA V. HUDSON其他文献

SHAWNA V. HUDSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHAWNA V. HUDSON', 18)}}的其他基金

Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance
使用量身定制的移动医疗干预措施来减少城市宫颈癌的差异,以提高阴道镜检查的出勤率
  • 批准号:
    10659894
  • 财政年份:
    2023
  • 资助金额:
    $ 5.47万
  • 项目类别:
Re-entry Supplement to Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者 (EXCELS) 扩展癌症教育的重返补充
  • 批准号:
    8843650
  • 财政年份:
    2013
  • 资助金额:
    $ 5.47万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8743195
  • 财政年份:
    2013
  • 资助金额:
    $ 5.47万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    9379052
  • 财政年份:
    2013
  • 资助金额:
    $ 5.47万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8917755
  • 财政年份:
    2013
  • 资助金额:
    $ 5.47万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    9326812
  • 财政年份:
    2013
  • 资助金额:
    $ 5.47万
  • 项目类别:
Extended Cancer Education for Longer-term Survivors (EXCELS) In Primary Care
初级保健中长期幸存者的扩展癌症教育 (EXCELS)
  • 批准号:
    8641008
  • 财政年份:
    2013
  • 资助金额:
    $ 5.47万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8133263
  • 财政年份:
    2011
  • 资助金额:
    $ 5.47万
  • 项目类别:
Predictors of Follow-Up Care Seeking Among Breast and Prostate Cancer Survivors
乳腺癌和前列腺癌幸存者寻求后续护理的预测因素
  • 批准号:
    8230599
  • 财政年份:
    2011
  • 资助金额:
    $ 5.47万
  • 项目类别:
Life After Cancer: Examining Survivor Transitions From Specialist to Primary Care
癌症后的生活:检查幸存者从专科护理到初级护理的转变
  • 批准号:
    8700972
  • 财政年份:
    2008
  • 资助金额:
    $ 5.47万
  • 项目类别:

相似国自然基金

GRACE与GRACE Follow-On无缝衔接关键技术研究
  • 批准号:
    41674006
  • 批准年份:
    2016
  • 资助金额:
    68.0 万元
  • 项目类别:
    面上项目
基于GRACE和GRACE Follow-On卫星的区域地下水模拟仿真技术研究
  • 批准号:
    41572220
  • 批准年份:
    2015
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目

相似海外基金

Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up
中年痴呆症风险因素的早期预测因素:35 年随访
  • 批准号:
    10596295
  • 财政年份:
    2023
  • 资助金额:
    $ 5.47万
  • 项目类别:
Earlier-Life Predictors of Midlife Risk Factors for Alzheimer's Disease: A 35-Year Follow-up
阿尔茨海默病中年危险因素的早期预测因素:35 年随访
  • 批准号:
    10460376
  • 财政年份:
    2021
  • 资助金额:
    $ 5.47万
  • 项目类别:
Predictors and consequences of long-term functional trajectories of older men: The Manitoba Follow-up Study
老年男性长期功能轨迹的预测因素和后果:马尼托巴随访研究
  • 批准号:
    356124
  • 财政年份:
    2016
  • 资助金额:
    $ 5.47万
  • 项目类别:
    Operating Grants
Biopsychosocial predictors of postpartum genito-pelvic pain: A two-year follow-up
产后生殖器盆腔疼痛的生物心理社会预测因素:两年随访
  • 批准号:
    355878
  • 财政年份:
    2016
  • 资助金额:
    $ 5.47万
  • 项目类别:
    Operating Grants
Multilevel Predictors of Follow-up after Anal Cancer Screening in HIV-infected Individuals
HIV 感染者肛门癌筛查后随访的多级预测因素
  • 批准号:
    9065069
  • 财政年份:
    2015
  • 资助金额:
    $ 5.47万
  • 项目类别:
Multilevel Predictors of Follow-up after Anal Cancer Screening in HIV-infected Individuals
HIV 感染者肛门癌筛查后随访的多级预测因素
  • 批准号:
    9149034
  • 财政年份:
    2015
  • 资助金额:
    $ 5.47万
  • 项目类别:
Multilevel Predictors of Follow-up after Anal Cancer Screening in HIV-infected Individuals
HIV 感染者肛门癌筛查后随访的多级预测因素
  • 批准号:
    9318345
  • 财政年份:
    2015
  • 资助金额:
    $ 5.47万
  • 项目类别:
Longitudinal Follow-up of Purging Syndromes: Outcome and Predictors
净化综合征的纵向随访:结果和预测因素
  • 批准号:
    8907197
  • 财政年份:
    2015
  • 资助金额:
    $ 5.47万
  • 项目类别:
Namibia ART Patient Tracing Intensification and Predictors of Loss to Follow-up
纳米比亚 ART 患者追踪强化和随访损失的预测因素
  • 批准号:
    8329246
  • 财政年份:
    2012
  • 资助金额:
    $ 5.47万
  • 项目类别:
Namibia ART Patient Tracing Intensification and Predictors of Loss to Follow-up
纳米比亚 ART 患者追踪强化和随访损失的预测因素
  • 批准号:
    8638890
  • 财政年份:
    2012
  • 资助金额:
    $ 5.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了